Australia's largest stock trading and investment forum Australia's #1 stock forum

RGS

Click for more information

0.00%

12.0¢ regeneus ltd

Ann: Regeneus receives R&D tax incentive refund of $2.4m, page-8

First 8 Last

Share
Profile

Follow
Biotechasx

76 Posts.

5

09/09/18

15:21

Post #: 35483055
Share

Originally posted by ninjasparda ↑

licence agreement is going to be q2 2019, there’s is more than half a year for the SP to drift

Expand

RGS business update states Q2 FY19, not Q2 calendar year 2019. Q2 Financial Year 2019 is Oct-Dec 2018, not in 6 months time.

" it is anticipated that a licence agreement will be secured in Q2 FY19 "

http://regeneus.com.au/investors/as...us-2018-full-year-results-and-business-update

Last edited by Biotechasx: 09/09/18

RGS Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 7 more messages in this thread...

First 8 Last

Add RGS (ASX) to my watchlist